{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:58:00Z","timestamp":1783108680198,"version":"3.54.6"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["HRD-1241701"],"award-info":[{"award-number":["HRD-1241701"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["HRD-1646729"],"award-info":[{"award-number":["HRD-1646729"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI111159"],"award-info":[{"award-number":["R21AI111159"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["program-P30 AI027767"],"award-info":[{"award-number":["program-P30 AI027767"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003382","name":"Core Research for Evolutional Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011531","name":"University of Alabama","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.nano.2020.102257","type":"journal-article","created":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T01:32:19Z","timestamp":1593307939000},"page":"102257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4+ effector (CD44high CD62Llow) and memory (CD44high CD62Lhigh) T-cells in immunized mice"],"prefix":"10.1016","volume":"29","author":[{"given":"Rajnish","family":"Sahu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skyla A.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamie T.","family":"Coats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo H.","family":"Giambartolomei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shree R.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vida A.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2020.102257_bb0005","series-title":"Handbook of Biologically Active Peptides","first-page":"571","article-title":"Lipo-peptides\/saccharides for peptide vaccine delivery","author":"Skwarczynski","year":"2013"},{"key":"10.1016\/j.nano.2020.102257_bb0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biomaterials.2017.12.019","volume":"159","author":"Dixit","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2020.102257_bb0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2020.102257_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/polym9060189","article-title":"Poly(lactic-co-glycolic acid): applications and future prospects for periodontal tissue regeneration","volume":"9","author":"Sun","year":"2017","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.nano.2020.102257_bb0025","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/21645515.2015.1102804","article-title":"Peptide\/protein vaccine delivery system based on PLGA particles","volume":"12","author":"Allahyari","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.nano.2020.102257_bb0030","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2020.102257_bb0035","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.nano.2020.102257_bb0040","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1021\/mp200198c","article-title":"Intracellular targeting of PLGA nanoparticles encapsulating antigenic peptide to the endoplasmic reticulum of dendritic cells and its effect on antigen cross-presentation in vitro","volume":"8","author":"Sneh-Edri","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2020.102257_bb0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biomaterials.2014.10.053","article-title":"CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses","volume":"40","author":"Rosalia","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2020.102257_bb0050","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3389\/fimmu.2018.02369","volume":"9","author":"Verma","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2020.102257_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/14760584.2018.1435279","article-title":"Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles","volume":"17","author":"Sahu","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.nano.2020.102257_bb0060","first-page":"217","article-title":"Chlamydia trachomatis: protective adaptive responses and prospects for a vaccine","volume":"412","author":"Poston","year":"2018","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.nano.2020.102257_bb0065","first-page":"300","article-title":"Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for Chlamydia in a Chlamydia screening trial","volume":"95","author":"Hoenderboom","year":"2019","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.nano.2020.102257_bb0070","doi-asserted-by":"crossref","first-page":"4827353","DOI":"10.1155\/2018\/4827353","article-title":"Association between prior Chlamydia trachomatis infection and ectopic pregnancy at a tertiary care hospital in South Western Uganda","volume":"2018","author":"Mpiima","year":"2018","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.nano.2020.102257_bb0075","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1586\/14760584.2016.1161510","article-title":"Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis","volume":"15","author":"Yu","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.nano.2020.102257_bb0080","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1128\/CVI.00460-12","article-title":"Fluorometric high-throughput assay for measuring chlamydial neutralizing antibody","volume":"19","author":"Southern","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.nano.2020.102257_bb0085","first-page":"2085","article-title":"Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine","volume":"8","author":"Fairley","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2020.102257_bb0090","doi-asserted-by":"crossref","first-page":"325101","DOI":"10.1088\/0957-4484\/23\/32\/325101","article-title":"Biodegradable PLGA85\/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide","volume":"23","author":"Taha","year":"2012","journal-title":"Nanotechnology"},{"key":"10.1016\/j.nano.2020.102257_bb0095","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.nano.2014.02.009","article-title":"Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice","volume":"10","author":"Dixit","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2020.102257_bb0100","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2217\/nnm-2016-0195","article-title":"Endocytosis and intracellular processing of nanoparticles in dendritic cells: routes to effective immunonanomedicines","volume":"11","author":"Tonigold","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2020.102257_bb0105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.micinf.2013.11.009","article-title":"A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge","volume":"16","author":"Cheng","year":"2014","journal-title":"Microbes Infect"},{"key":"10.1016\/j.nano.2020.102257_bb0110","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3389\/fimmu.2018.02224","article-title":"Nanoparticle vaccines against infectious diseases","volume":"9","author":"Pati","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2020.102257_bb0115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12274-019-2301-3","article-title":"Critical size limit of biodegradable nanoparticles for enhanced lymph node trafficking and paracortex penetration","volume":"12","author":"Howard","year":"2019","journal-title":"Nano Research"},{"key":"10.1016\/j.nano.2020.102257_bb0120","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.nano.2020.102257_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa8205","article-title":"VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells","volume":"348","author":"Stary","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.nano.2020.102257_bb0130","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1016\/j.vaccine.2017.01.023","article-title":"Status of vaccine research and development of vaccines for Chlamydia trachomatis infection","volume":"37","author":"Poston","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2020.102257_bb0135","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.intimp.2015.09.011","article-title":"Down-regulation of Th2 immune responses by sublingual administration of poly (lactic-co-glycolic) acid (PLGA)-encapsulated allergen in BALB\/c mice","volume":"29","author":"Salari","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.nano.2020.102257_bb0140","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.molimm.2015.09.011","article-title":"PLGA (85:15) nanoparticle based delivery of rL7\/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: a promising alternate to traditional adjuvants","volume":"68","author":"Singh","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.nano.2020.102257_bb0145","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejpb.2018.11.003","article-title":"Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles","volume":"133","author":"Kabiri","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2020.102257_bb0150","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2147\/IJN.S3938","article-title":"Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers","volume":"3","author":"Mukherjee","year":"2008","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2020.102257_bb0155","doi-asserted-by":"crossref","first-page":"935","DOI":"10.31557\/APJCP.2020.21.4.935","article-title":"The potential of atractylodin-loaded PLGA nanoparticles as chemotherapeutic for cholangiocarcinoma","volume":"21","author":"Muhamad","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.nano.2020.102257_bb0160","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1039\/C9FO00901A","article-title":"Enhanced curcumin solubility and antibacterial activity by encapsulation in PLGA oily core nanocapsules","volume":"11","author":"Gao","year":"2020","journal-title":"Food Funct"},{"key":"10.1016\/j.nano.2020.102257_bb0165","doi-asserted-by":"crossref","first-page":"119025","DOI":"10.1016\/j.ijpharm.2020.119025","article-title":"PLGA nanoparticles embedding molybdenum cluster salts: influence of chemical composition on physico-chemical properties, encapsulation efficiencies, colloidal stabilities and in vitro release","volume":"576","author":"Dollo","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2020.102257_bb0170","first-page":"100030","article-title":"Comparison of bulk and microfluidics methods for the formulation of poly-lactic-co-glycolic acid (PLGA) nanoparticles modified with cell-penetrating peptides of different architectures","volume":"1","author":"Streck","year":"2019","journal-title":"Int J Pharm X"},{"key":"10.1016\/j.nano.2020.102257_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061885","article-title":"A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge","volume":"8","author":"Manish","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2020.102257_bb0180","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1016\/j.vaccine.2015.04.030","article-title":"Recombinant L7\/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB\/c mice against the virulent B. abortus 544 infection","volume":"33","author":"Singh","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2020.102257_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02980037","article-title":"Control of encapsulation efficiency and initial burst in polymeric microparticle systems","volume":"27","author":"Yeo","year":"2004","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.nano.2020.102257_bb0190","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1128\/IAI.66.9.4564-4567.1998","article-title":"A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection","volume":"66","author":"Williams","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.nano.2020.102257_bb0195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2016.08.059","article-title":"PLGA nano\/micro particles encapsulated with pertussis toxoid (PTd) enhances Th1\/Th17 immune response in a murine model","volume":"513","author":"Li","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2020.102257_bb0200","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1128\/IAI.70.3.1097-1105.2002","article-title":"Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective","volume":"70","author":"Shaw","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.nano.2020.102257_bb0205","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1084\/jem.20040317","article-title":"The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80\/86 costimulation","volume":"199","author":"Fujii","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.nano.2020.102257_bb0210","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1086\/377134","article-title":"Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens","volume":"188","author":"Moore","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nano.2020.102257_bb0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.0019-2805.2001.01354.x","article-title":"Fc receptor regulation of protective immunity against Chlamydia trachomatis","volume":"105","author":"Moore","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.nano.2020.102257_bb0220","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1074\/jbc.M510182200","article-title":"Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions. Evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen","volume":"281","author":"O'Connell","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2020.102257_bb0225","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-3083.2009.02267.x","article-title":"Effects of CD14, TLR2, TLR4, LPB, and IL-6 gene polymorphisms on Chlamydia pneumoniae growth in human macrophages in vitro","volume":"70","author":"Poikonen","year":"2009","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.nano.2020.102257_bb0230","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2020.102257_bb0235","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1080\/21691401.2016.1276924","article-title":"A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles' characteristics and efficacy of intracellular delivery","volume":"45","author":"Sahin","year":"2017","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.nano.2020.102257_bb0240","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2147\/IJN.S154968","article-title":"Understanding the translocation mechanism of PLGA nanoparticles across round window membrane into the inner ear: a guideline for inner ear drug delivery based on nanomedicine","volume":"13","author":"Zhang","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2020.102257_bb0245","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","article-title":"From vaccines to memory and back","volume":"33","author":"Sallusto","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.nano.2020.102257_bb0250","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1016\/j.vaccine.2014.08.016","article-title":"Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis","volume":"32","author":"Cappellano","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2020.102257_bb0255","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00215-18","article-title":"The mucosal vaccine adjuvant LT(R192G\/L211A) or dmLT","volume":"3","author":"Clements","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.nano.2020.102257_bb0260","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1016\/j.vaccine.2012.01.017","article-title":"High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge","volume":"30","author":"Picard","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2020.102257_bb0265","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/CVI.00521-12","article-title":"Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection","volume":"20","author":"Alam","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.nano.2020.102257_bb0270","first-page":"119","article-title":"Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 Sao Paulo epidemic","volume":"11","author":"Pannuti","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.nano.2020.102257_bb0275","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/jps.21970","article-title":"Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery","volume":"99","author":"Rao","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2020.102257_bb0280","first-page":"598","article-title":"Modification of PLGA nanoparticles for improved properties as a 99mTc-labeled agent in sentinel lymph node detection","volume":"28","author":"Subramanian","year":"2013","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nano.2020.102257_bb0285","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2004.09.014","article-title":"Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery","volume":"102","author":"Chong","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2020.102257_bb0290","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ejpb.2013.06.017","article-title":"Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity","volume":"85","author":"Pawar","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2020.102257_bb0295","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ymeth.2006.05.017","article-title":"Microparticle-based technologies for vaccines","volume":"40","author":"O'Hagan","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.nano.2020.102257_bb0300","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.addr.2011.05.021","article-title":"Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations","volume":"63","author":"Hamdy","year":"2011","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963420301118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963420301118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:32:47Z","timestamp":1778617967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963420301118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":60,"alternative-id":["S1549963420301118"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2020.102257","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4+ effector (CD44high CD62Llow) and memory (CD44high CD62Lhigh) T-cells in immunized mice","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2020.102257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102257"}}